BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15617338)

  • 1. [Clinical and pathological study on liver fibrosis in viral hepatitis].
    Xin S; Mao Y; Wang L; Li Y; Li L; Yu H; Zhao M; Zhang S; Wang S; Wang X; Chen L; Zhou X; Zhou Y; Zou Z; Tang S; Huangpu Y; Zhang L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):240-3. PubMed ID: 15617338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
    Xu GG; Luo CY; Wu SM; Wang CL
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The detection and clinical significance of hepatic fibrosis index].
    Xu CH; Meng DM; Lv SL; Kang P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):50-2. PubMed ID: 20848851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
    Zheng M; Cai W; Weng H; Liu R
    Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
    Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP; Feng XR; Dai L; Ding HB; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis].
    Liang XH; Zheng H
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):67-8. PubMed ID: 12575242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
    Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha].
    Deng L; Zhou Y; Peng X; Deng H; Deng Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():66-7. PubMed ID: 11509145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between HBsAg, HCV expression in cancerous and pericancer tissues of hepatocellular carcinoma and liver fibrosis markers in serum].
    Xin YN; Xuan SY; Shi GJ; Chen H; Sun Y; Zhang J
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):513-5. PubMed ID: 16042887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination and significance of serum markers for fibrosis in patients with chronic hepatitis].
    Cai W; Zheng M; Weng H; Liu R
    Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):448-51. PubMed ID: 11798612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D
    Acta Clin Croat; 2010 Sep; 49(3):257-65. PubMed ID: 21462814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between the levels of serum fibrosis marks and morphometric quantitative measurement of hepatic histological fibrosis].
    Xie S; Yao J; Zheng S; Yao C; Zheng R
    Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):203-5. PubMed ID: 10951617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J; Łoch T; Jabłońska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the ELISA and the enhanced chemiluminescence immunoassay in use to determine the serum markers for liver fibrosis].
    Guo JX; Ma HB; Li YL; Xu J; Yang LH; Shi JB; Li B; Liu AX; Li XX; Li BA; Mao YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):71-3. PubMed ID: 19799025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.